Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

Ruemmele, T., Macedo, R., Stein, M. N., Chan, H. T., Mapara, M. Y., Jacquemont, C. F., & Reshef, R. (2025). Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1543622
Authors:
Tyler Ruemmele
Rodney Macedo
Mark N Stein
Hei Ton Chan
Markus Y Mapara
Céline F Jacquemont
Ran Reshef
Affiliated Authors:
Tyler Ruemmele
Rodney Macedo
Mark N Stein
Hei Ton Chan
Markus Y Mapara
Ran Reshef
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
Author Keywords:
chimeric antigen receptor (car t)
cytokine release syndrome (crs)
emapalumab
interferon gamma (ifn gamma)
prostate stem cell antigen (psca)
immune effector cell associated hlh-like syndrome (iec-hs)
prostate specific antigen (psa)
car (chimeric antigen receptor) t cells
interferon gamma (ifnγ)
elink
Publication Type:
Article
Unique ID:
10.3389/fonc.2025.1543622
PMID:
40236652
DOI:
10.3389/fonc.2025.1543622
Journal:
Frontiers in Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: